Acadia buys pain drug maker, as it seeks to build on psychosis treatment

Acadia buys pain drug maker, as it seeks to build on psychosis treatment

STAT Plus: Acadia Pharmaceuticals buys pain drug maker, part of effort to expand on psychosis treatment

By MATTHEW HERPER

GEORGE FREY/AFP VIA GETTY IMAGES

The company believes the drug from CerSci, a small Texas firm, could get around redundancies that prevent other pain medications from working.

READ MORE